No Data
No Data
No Data
Betta Pharmaceuticals Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Press Release: C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
C4 Therapeutics Announces Closing of $25 Million Equity Investment by Betta Pharmaceuticals
The FDA Clears C4 Therapeutics' Investigational New Drug Application For CFT8919 For Non-small Cell Lung Cancer; C4T Expects To Initiate Trials Outside Greater China After Betta Pharmaceuticals Concludes Phase 1 Dose Escalation Study In Greater China
Betta Pharmaceuticals Gets Nod for Voronib Tablets' Listing
C4 Therapeutics, Betta Pharmaceuticals Sign Deal to Develop, Commercialize CFT8919 in Greater China
No Data
No Data